National
After targeting youth, state lawmakers now going after the rights of LGBTQ adults
Legislators are also teeing up challenges to same-sex marriage
The proliferation of anti-LGBTQ bills proposed by state legislatures across the country, which ticked up dramatically in 2021 and has since increased year-over-year, looks different in 2025.
Efforts that once focused on school sports and pediatric gender care have now broadened, as many advocates warned they would, to target adult life and the legal scaffolding of hard-won freedoms like same-sex marriage.
LGBTQ issues remain fraught political battlegrounds, but the fight has shifted to driver’s licenses, hospital policies, state-worker speech rules, and even marriage licenses — exposing these communities to greater risk of civil-rights violations.
This shift comes at a moment when legal avenues for challenging discrimination by state governments or the Trump-Vance administration have narrowed significantly, even as rhetorical and political attacks intensify.
The new types of bills
By the numbers, this year is shaping up to be the worst in recent memory. The ACLU tracked 520 anti-LGBTQ bills in 2023, 533 in 2024, and by February the organization had already logged 339, an accelerated pace for 2025.
Predictably, these legislative efforts are clustered in conservative places like Texas, where state lawmakers teed up 32 anti-trans bills on the first day of pre-filing for 2025, as GLAAD noted.
At the same time, however, the group reports that the year kicked off with similar activity in far bluer statehouses located in places like Massachusetts, Colorado, and New York.
The new crop of bills share some distinguishing features. For instance, Alabama, Arizona, Georgia, and Illinois are considering (or have enacted, in Alabama’s case) proposals to adopt restrictive definitions of sex and gender.
Not only does the establishment of a legal definition for gender based on a fixed binary that must be determined by one’s sex at birth exclude the recognition of people who are trans or have other gender diverse identities, but it also carries significant downstream impacts.
President Donald Trump has already demonstrated how this can work. Issued on the first day of his second term, his Executive Order 14168 recast “sex” across all federal policy as a fixed category that is limited to “male” or “female,” defined at “conception,” and unchangeable.
Pursuant to the order, the administration mandated that agencies replace all mention of “gender” with “sex,” strip gender self-identification options from passports, and halt funding for anything deemed “gender ideology,” including gender‑affirming care.
With respect to restrictions on gender markers on passports and official documents, the consequences for Americans who are not cisgender are far-reaching, touching areas of their lives from housing to employment and travel.
Georgia, meanwhile, previewed how conservative lawmakers can restrict guideline-directed best practices medical interventions for not just transgender youth, but adults as well, with a bill introduced this year that would bar coverage by state employees’ health benefits plans.
Georgia has also enacted a law prohibiting all gender-affirming care (hormones, surgeries, and even personal funding of such care) for incarcerated individuals in state prisons, which came after Trump’s executive order requiring the Bureau of Prisons to halt funding for these treatments and move trans women inmates into men’s facilities.
Broadened healthcare restrictions did not necessarily start this year, however. Florida passed a law in 2023, for example, that requires trans adults to receive in-person, state-approved informed consent for gender-affirming care, while banning nurse practitioners and telehealth delivery of such treatments, thereby limiting access for patients.
Following years of conservative activism focused on censoring pro-LGBTQ speech from schools — banning books and other materials with gay or trans characters or themes; restricting classroom instruction on matters of sexual orientation and gender identity — some states have taken a new tack in 2025: protecting anti-LGBTQ speech.
Once again, the scope of these efforts now extends beyond educational institutions and their focus is broadened from youth to youth and adults.
Montana’s Free to Speak Act, enacted in May, protects students and public employees from being disciplined for refusing to use a person’s preferred name or pronouns, establishing a private right of action allowing affected individuals to sue for injunctive relief, monetary damages, and attorney fees.
Lawmakers in Florida are going even further with a proposal that would bar public employers from requiring the use of trans individuals’ preferred pronouns, remove “nonbinary” as an option on state job applications, and make LGBTQ+ cultural competence training optional rather than mandatory.
Marriage equality under fire
On Monday, news outlets around the world reported on the return of Kim Davis. The thrice divorced former Kentucky county clerk has asked the U.S. Supreme Court to hear her case, which seeks to overturn the High Court’s precedent setting ruling in Obergefell v. Hodges that established marriage equality as the law of the land in 2015.
Some legal experts believe the gambit is a long shot. Others are less confident, pointing to the establishment of a 6-3 conservative supermajority in October 2020 and Justice Clarence Thomas’s concurring statement in the 2022 decision overturning abortion rights, where he expressed interest in revisiting the marriage decision.
In what may be a harbinger of another battle over same-sex marriage, or a sign that the matter was never settled in the first place, five states this year have considered non-binding resolutions asking the justices to overturn Obergefell: South Dakota, North Dakota, Idaho, Michigan, and Montana.
Other measures have been more concrete. In Tennessee and several other states, lawmakers introduced “covenant marriage” bills defining marriage as a union between “one male and one female” with heightened divorce restrictions — a move that would effectively exclude same-sex couples from that marital track. While none have yet been passed or enacted, they illustrate how legislatures can reshape marriage law without directly challenging Obergefell.
Such bills raise a potential clash with the Respect for Marriage Act, legislation passed during the Biden-Harris administration that requires states to recognize same-sex marriages performed elsewhere but does not require them to issue licenses.
A Wider Bridge on Friday announced it will shut down at the end of the month.
The group that “mobilizes the LGBTQ community to fight antisemitism and support Israel and its LGBTQ community” in a letter to supporters said financial challenges prompted the decision.
“After 15 years of building bridges between LGBTQ communities in North America and Israel, A Wider Bridge has made the difficult decision to wind down operations as of Dec. 31, 2025,” it reads.
“This decision comes after challenging financial realities despite our best efforts to secure sustainable funding. We deeply appreciate our supporters and partners who made this work possible.”
Arthur Slepian founded A Wider Bridge in 2010.
The organization in 2016 organized a reception at the National LGBTQ Task Force’s Creating Change Conference in Chicago that was to have featured to Israeli activists. More than 200 people who protested against A Wider Bridge forced the event’s cancellation.
A Wider Bridge in 2024 urged the Capital Pride Alliance and other Pride organizers to ensure Jewish people can safely participate in their events in response to an increase in antisemitic attacks after Hamas militants attacked Israel on Oct. 7, 2023.
The Jewish Telegraphic Agency reported authorities in Vermont late last year charged Ethan Felson, who was A Wider Bridge’s then-executive director, with lewd and lascivious conduct after alleged sexual misconduct against a museum employee. Rabbi Denise Eger succeeded Felson as A Wider Bridge’s interim executive director.
A Wider Bridge in June honored U.S. Rep. Debbie Wasserman Schultz (D-Fla.) at its Pride event that took place at the Capital Jewish Museum in D.C. The event took place 15 days after a gunman killed two Israeli Embassy employees — Yaron Lischinsky and Sarah Milgrim — as they were leaving an event at the museum.
“Though we are winding down, this is not a time to back down. We recognize the deep importance of our mission and work amid attacks on Jewish people and LGBTQ people – and LGBTQ Jews at the intersection,” said A Wider Bridge in its letter. “Our board members remain committed to showing up in their individual capacities to represent queer Jews across diverse spaces — and we know our partners and supporters will continue to do the same.”
Editor’s note: Washington Blade International News Editor Michael K. Lavers traveled to Israel and Palestine with A Wider Bridge in 2016.
The White House
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
President made announcement on Friday
President Donald Trump met with leaders from some of the world’s largest pharmaceutical companies at the White House on Friday to announce his new “Trump Rx” plan and outline efforts to reduce medication costs for Americans.
During the roughly 47-minute meeting in the Roosevelt Room, Trump detailed his administration’s efforts to cut prescription drug prices and make medications more affordable for U.S. patients.
“Starting next year, American drug prices will come down fast, furious, and will soon be among the lowest in the developed world,” Trump said during the meeting. “For decades, Americans have been forced to pay the highest prices in the world for prescription drugs by far … We will get the lowest price of anyone in the world.”
Trump signed an executive order in May directing his administration “to do everything in its power to slash prescription drug prices for Americans while getting other countries to pay more.”
“This represents the greatest victory for patient affordability in the history of American health care, by far, and every single American will benefit,” he added.
Several pharmaceutical executives stood behind the president during the announcement, including Sanofi CEO Paul Hudson, Novartis CEO Vas Narasimhan, Genentech CEO Ashley Magargee, Boehringer Ingelheim (USA) CEO Jean-Michel Boers, Gilead Sciences CEO Dan O’Day, Bristol Myers Squibb General Counsel Cari Gallman, GSK CEO Emma Walmsley, Merck CEO Robert Davis, and Amgen Executive Vice President Peter Griffith.
Also in attendance were Health and Human Services Secretary Robert F. Kennedy Jr., Commerce Secretary Howard Lutnick, Centers for Medicare and Medicaid Services Administrator Mehmet Oz, and Food and Drug Administration Commissioner Marty Makary.
Under the Trump Rx plan, the administration outlined a series of proposed drug price changes across multiple companies and therapeutic areas. Among them were reductions for Amgen’s cholesterol-lowering drug repatha from $573 to $239; Bristol Myers Squibb’s HIV medication reyataz from $1,449 to $217; Boehringer Ingelheim’s type 2 diabetes medication jentadueto from $525 to $55; Genentech’s flu medication xofluza from $168 to $50; and Gilead Sciences’ hepatitis C medication epclusa from $24,920 to $2,425.
Additional reductions included several GSK inhalers — such as the asthma inhaler advair diskus 500/50, from $265 to $89 — Merck’s diabetes medication januvia from $330 to $100, Novartis’ multiple sclerosis medication mayzent from $9,987 to $1,137, and Sanofi’s blood thinner plavix from $756 to $16. Sanofi insulin products would also be capped at $35 per month’s supply.
These prices, however, would only be available to patients who purchase medications directly through TrumpRx. According to the program’s website, TrumpRx “connects patients directly with the best prices, increasing transparency, and cutting out costly third-party markups.”
Kennedy spoke after Trump, thanking the president for efforts to lower pharmaceutical costs in the U.S., where evidence has shown that drug prices — including both brand-name and generic medications — are nearly 2.78 times higher than prices in comparable countries. According to the Pharmaceutical Research and Manufacturers of America, roughly half of every dollar spent on brand-name drugs goes to entities that play no role in their research, development, or manufacturing.
“This is affordability in action,” Kennedy said. “We are reversing that trend and making sure that Americans can afford to get the life-saving solutions.”
Gilead CEO Dan O’Day also spoke about how the restructuring of drug costs under TrumpRx, combined with emerging technologies, could help reduce HIV transmission — a virus that, if untreated, can progress to AIDS. The LGBTQ community remains disproportionately affected by HIV.
“Thank you, Mr. President — you and the administration,” O’Day said. “I think this objective of achieving the commitment to affordability and future innovation is extraordinary … We just recently launched a new medicine that’s only given twice a year to prevent HIV, and we’re working with Secretary Kennedy and his entire team, as well as the State Department, as a part of your strategy to support ending the epidemic during your term.
“I’ve never been more optimistic about the innovation that exists across these companies and the impact this could have on America’s health and economy,” he added.
Trump interjected, asking, “And that’s working well with HIV?”
“Yes,” O’Day replied.
“It’s a big event,” Trump said.
“It literally prevents HIV almost 100 percent given twice a year,” O’Day responded.
A similar anti-HIV medication is currently prescribed more than injectable form mentioned by O’Day. PrEP, is a medication regimen proven to significantly reduce HIV infection rates for people at high risk. Without insurance, brand-name Truvada can cost roughly $2,000 per month, while a generic version costs about $60 per month.
Even when medication prices are reduced, PrEP access carries additional costs, including clinic and laboratory fees, office visits, required HIV and sexually transmitted infection testing, adherence services and counseling, and outreach to potentially eligible patients and providers.
According to a 2022 study, the annual total cost per person for PrEP — including medication and required clinical and laboratory monitoring — is approximately $12,000 to $13,000 per year.
The TrumpRx federal platform website is now live at TrumpRx.gov, but the program is not slated to begin offering reduced drug prices until January.
The White House
EXCLUSIVE: Democracy Forward files FOIA lawsuit after HHS deadnames Rachel Levine
Trans former assistant health secretary’s name changed on official portrait
Democracy Forward, a national legal organization that works to advance democracy and social progress through litigation, policy and public education, and regulatory engagement, filed a lawsuit Friday in federal court seeking to compel the U.S. Department of Health and Human Services to release information related to the alteration of former Assistant Secretary for Health Adm. Rachel Levine’s official portrait caption.
The lawsuit comes in response to the slow pace of HHS’s handling of multiple Freedom of Information Act requests — requests that federal law requires agencies to respond to within 20 working days. While responses can take longer due to backlogs, high request volumes, or the need for extensive searches or consultations, Democracy Forward says HHS has failed to provide any substantive response.
Democracy Forward’s four unanswered FOIA requests, and the subsequent lawsuit against HHS, come days after someone in the Trump-Vance administration changed Levine’s official portrait in the Hubert H. Humphrey Building to display her deadname — the name she used before transitioning and has not used since 2011.
According to Democracy Forward, HHS “refused to release any records related to its morally wrong and offensive effort to alter former Assistant Secretary for Health Admiral Rachel Levine’s official portrait caption.” Levine was the highest-ranking openly transgender government official in U.S. history and served as assistant secretary for health and as an admiral in the U.S. Public Health Service Commissioned Corps from 2021 to 2025.
Democracy Forward President Skye Perryman spoke about the need to hold the Trump-Vance administration accountable for every official action, especially those that harm some of the most targeted Americans, including trans people.
“The question every American should be asking remains: what is the Trump-Vance administration hiding? For an administration that touts its anti-transgender animus and behavior so publicly, its stonewalling and silence when it comes to the people’s right to see public records about who was behind this decision is deafening,” Perryman said.
“The government’s obligation of transparency doesn’t disappear because the information sought relates to a trailblazing former federal official who is transgender. It’s not complicated — the public is entitled to know who is making decisions — especially decisions that seek to alter facts and reality, erase the identity of a person, and affect the nation’s commitment to civil rights and human dignity.”
“HHS’s refusal to respond to these lawful requests raises more serious concerns about transparency and accountability,” Perryman added. “The public has every right to demand answers — to know who is behind this hateful act — and we are going to court to get them.”
The lawsuit also raises questions about whether the alteration violated federal accuracy and privacy requirements governing Levine’s name, and whether the agency improperly classified the change as an “excepted activity” during a lapse in appropriations. By failing to make any determination or produce any records, Democracy Forward argues, HHS has violated its obligations under federal law.
The case, Democracy Forward Foundation v. U.S. Department of Health and Human Services, was filed in the U.S. District Court for the District of Columbia. The legal team includes Anisha Hindocha, Daniel McGrath, and Robin Thurston.
The Washington Blade reached out to HHS, but has not received any comment.
The lawsuit and four FOIA requests are below:
Long-awaited ‘Pillion’ surpasses the sexy buzz
Trump’s ‘American people derangement syndrome’
Reasons to be optimistic about 2026
Using movement to boost your mental health during holidays
Protecting the trans community is not optional for elected allies and candidates
Reasons to be optimistic about 2026
America is going in the wrong direction for intersex children
Rush reopens after renewing suspended liquor license
Long-awaited ‘Pillion’ surpasses the sexy buzz
